Nuvectis Pharma, Inc. (NVCT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 25.4M | 31.71M | 35.59M | 27.01M | 30.15M | 18.61M | 17.31M | 18.3M | 19.71M | 19.18M | 22.26M | 24.94M | 16.21M | 20.41M | 24.87M | 14.24M | 17.62M | 5.83M | 6.81M | 7.21M |
| Cash & Short-Term Investments | 25.13M | 31.63M | 35.44M | 26.79M | 29.86M | 18.53M | 17.17M | 18.12M | 19.46M | 19.13M | 22.06M | 24.6M | 15.47M | 19.99M | 23.64M | 13.57M | 16.69M | 5.74M | 6.81M | 7.21M |
| Cash Only | 25.13M | 31.63M | 35.44M | 26.79M | 29.86M | 18.53M | 17.17M | 18.12M | 19.46M | 19.13M | 22.06M | 24.6M | 15.47M | 19.99M | 23.64M | 13.57M | 16.69M | 5.74M | 6.81M | 7.21M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 268K | 75K | 145K | 214K | 284K | 74K | 138K | 182K | 250K | 59K | 203K | 341K | 740K | 412K | 1.23M | 666K | 925K | 91K | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 824K | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 824K | 0 | 0 |
| Total Assets | 25.4M | 31.71M | 35.59M | 27.01M | 30.15M | 18.61M | 17.31M | 18.3M | 19.71M | 19.18M | 22.26M | 24.94M | 16.21M | 20.41M | 24.87M | 14.24M | 17.62M | 6.66M | 6.81M | 7.21M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -15.76% | 70.41% | 105.62% | 47.6% | 52.93% | -3.01% | -22.26% | -26.63% | 21.63% | -5.98% | -10.47% | 75.17% | -8% | 206.52% | 265.19% | 97.37% | - | - | - | - |
| Total Current Liabilities | 11.18M | 13.3M | 11.58M | 10.13M | 9.19M | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M | 5.58M | 4.61M | 3.93M | 6.19M | 4.49M | 2.74M | 3.06M | 2.42M | 495K | 389K |
| Accounts Payable | 4.7M | 6.27M | 6.44M | 4.98M | 2.99M | 2.5M | 2.26M | 1.85M | 1.76M | 2.77M | 3.49M | 1.8M | 2.1M | 2.91M | 2.25M | 1.43M | 1.35M | 1.06M | 495K | 389K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.48M | 7.02M | 140K | 77K | 5.04M | 5.56M | 4.05M | 3.61M | 0 | 3.8M | 1.93M | 1.84M | 1.68M | 2.38M | 640K | 173K | 92K | 142K | 0 | 0 |
| Current Ratio | 2.27x | 2.38x | 3.07x | 2.66x | 3.28x | 2.09x | 2.74x | 3.17x | 3.46x | 2.75x | 3.99x | 5.41x | 4.12x | 3.30x | 5.54x | 5.20x | 5.76x | 2.41x | 13.76x | 18.54x |
| Quick Ratio | 2.27x | 2.38x | 3.07x | 2.66x | 3.28x | 2.09x | 2.74x | 3.17x | 3.46x | 2.75x | 3.99x | 5.41x | 4.12x | 3.30x | 5.54x | 5.20x | 5.76x | 2.41x | 13.76x | 18.54x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.25M | 15.25M | 11.22M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.25M | 15.25M | 11.22M |
| Total Liabilities | 11.18M | 13.3M | 11.58M | 10.13M | 9.19M | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M | 5.58M | 4.61M | 3.93M | 6.19M | 4.49M | 2.74M | 3.06M | 17.66M | 15.74M | 11.61M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -25.13M | -31.63M | -35.44M | -26.79M | -29.86M | -18.53M | -17.17M | -18.12M | -19.46M | -19.13M | -22.06M | -24.6M | -15.47M | -19.99M | -23.64M | -13.57M | -16.69M | -5.74M | -6.81M | -7.21M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 14.22M | 18.41M | 24.01M | 16.87M | 20.95M | 9.71M | 10.99M | 12.53M | 14.02M | 12.2M | 16.69M | 20.33M | 12.27M | 14.22M | 20.37M | 11.5M | 14.56M | -11.01M | -8.93M | -4.4M |
| Equity Growth % | -32.14% | 89.57% | 118.45% | 34.67% | 49.44% | -20.39% | -34.13% | -38.38% | 14.24% | -14.19% | -18.1% | 76.8% | -15.69% | 229.17% | 328.1% | 361.36% | 44218.18% | - | - | - |
| Book Value per Share | 0.61 | 0.84 | 1.06 | 0.79 | 1.05 | 0.50 | 0.64 | 0.74 | 0.85 | 0.70 | 1.04 | 1.34 | 0.83 | 0.97 | 1.45 | 0.90 | 1.14 | -0.87 | -0.70 | -0.35 |
| Total Shareholders' Equity | 14.22M | 18.41M | 24.01M | 16.87M | 20.95M | 9.71M | 10.99M | 12.53M | 14.02M | 12.2M | 16.69M | 20.33M | 12.27M | 14.22M | 20.37M | 11.5M | 14.56M | -11.01M | -8.93M | -4.4M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -105.74M | -99.69M | -92.37M | -84.91M | -78.58M | -73.25M | -67M | -62.84M | -58.42M | -54.24M | -47.62M | -41.74M | -36.03M | -31.98M | -25.29M | -19.41M | -15.84M | -12.9M | -10.64M | -5.97M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |